Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Global X Genomics & Biotechnology ETF (GNOM)

Global X Genomics & Biotechnology ETF (GNOM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Global X Mgt
  • Assets Under Management 46,925,000
  • Market Capitalization, $K 46,925
  • Shares Outstanding, K 2,500
  • 60-Month Beta 1.24
  • Price/Earnings ttm -17.61
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.68%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.58 +18.42%
on 06/12/20
18.97 -2.75%
on 07/09/20
+1.56 (+9.24%)
since 06/10/20
3-Month
13.15 +40.26%
on 04/13/20
18.97 -2.75%
on 07/09/20
+5.10 (+38.15%)
since 04/09/20
52-Week
10.16 +81.59%
on 03/18/20
18.97 -2.75%
on 07/09/20
+3.49 (+23.33%)
since 07/10/19

Most Recent Stories

More News
Top 8 Coronavirus (COVID 19) Test Kit Manufacturers in Europe - Altona Diagnostics, Biomaxima, Genomica, and many more in SpendEdge's Latest Article

SpendEdge is a leading procurement intelligence and strategic sourcing partner for leading Fortune 500 firms and several other companies. The company's latest procurement platform - SpendEdge Insights...

GNOM : 18.44 (-1.81%)
ETFs Under $20 From 5 Hottest Zones

Let us dig into some of the ETFs that are below $20 and are from the hottest areas currently. These low-priced ETFs could lead to huge gains in the coming months.

SDIV : 11.13 (+0.27%)
IEZ : 8.24 (+3.00%)
SILJ : 12.86 (+0.16%)
KBWD : 13.03 (+3.09%)
GNOM : 18.44 (-1.81%)
Race for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain

The COVID-19 pandemic has kept biotech players all over the world on their toes for a vaccine. This new opportunity has made the sector the most attractive one to investors.

JNJ : 142.50 (+0.01%)
SNY : 50.32 (-0.45%)
PFE : 33.83 (+1.11%)
MRK : 76.74 (+0.07%)
MRNA : 62.57 (-3.69%)
GSK : 39.91 (-1.14%)
NVAX : 94.35 (-2.02%)
IBB : 139.12 (-1.03%)
XBI : 114.84 (-1.09%)
BBH : 167.09 (-0.91%)
BBC : 42.59 (-1.69%)
ARKG : 55.72 (-3.03%)
BNTX : 70.00 (+6.69%)
GNOM : 18.44 (-1.81%)
Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up

Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.

AZN : 53.76 (-0.39%)
MRNA : 62.57 (-3.69%)
GSK : 39.91 (-1.14%)
NVAX : 94.35 (-2.02%)
CNCR : 27.02 (-1.78%)
INO : 23.36 (+0.39%)
PTH : 128.23 (-0.97%)
BBC : 42.59 (-1.69%)
BTEC : 45.74 (-1.04%)
ARKG : 55.72 (-3.03%)
IDN : 8.04 (+0.63%)
VXRT : 7.98 (-2.56%)
GNOM : 18.44 (-1.81%)
Genomics ETF (GNOM) Hits New 52-Week High

The ETF GNOM hit a 52-week high on May 22. Can it rally further?

GNOM : 18.44 (-1.81%)
Profit from the Genomics Market Momentum With These ETFs

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

GSK : 39.91 (-1.14%)
PBE : 59.92 (-1.32%)
ARKG : 55.72 (-3.03%)
GNOM : 18.44 (-1.81%)
IDNA : 39.03 (-1.34%)
4 Sector ETFs That Beat the Market in Q4

While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.

DIA : 261.15 (+1.52%)
SOXX : 281.72 (-0.08%)
IEZ : 8.24 (+3.00%)
BBC : 42.59 (-1.69%)
SMH : 160.01 (-0.37%)
PXJ : 2.33 (+2.64%)
SIL : 39.47 (+0.20%)
XSD : 117.54 (-0.52%)
SBIO : 42.05 (-0.80%)
XPH : 43.35 (+0.05%)
QQQ : 264.19 (+0.77%)
SPY : 317.85 (+1.10%)
GNOM : 18.44 (-1.81%)
SILJ : 12.86 (+0.16%)
Beyond Biotech, 5 ETFs Up At Least 10% in Q4

Apart from biotech, these ETFs are seeing solid momentum in the ongoing quarter.

BBC : 42.59 (-1.69%)
PAK : 23.87 (+1.35%)
SBIO : 42.05 (-0.80%)
JO : 29.86 (-1.78%)
SEA : 8.32 (+0.30%)
UUP : 26.11 (-0.15%)
GNOM : 18.44 (-1.81%)
SILJ : 12.86 (+0.16%)
CHIR : 18.35 (+0.17%)
Biotech Tops in November: Best ETFs & Stocks

The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.

CNCR : 27.02 (-1.78%)
BBC : 42.59 (-1.69%)
BBP : 48.73 (+0.37%)
GBT : 70.98 (+2.37%)
PTI : 1.3300 (-0.75%)
VRTX : 294.45 (-0.32%)
CLVS : 6.62 (-1.19%)
MYOV : 18.10 (-3.21%)
CNST : 29.58 (+1.54%)
KRTX : 96.56 (-1.29%)
CRSP : 89.61 (-4.69%)
ARKG : 55.72 (-3.03%)
GNOM : 18.44 (-1.81%)
Genomics ETFs Surge on CRISPR's Gene Editing Progress

The release of encouraging data on the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders puts emphasis on some genomic ETFs.

PBE : 59.92 (-1.32%)
VRTX : 294.45 (-0.32%)
CRSP : 89.61 (-4.69%)
ARKG : 55.72 (-3.03%)
IDNA : 39.03 (-1.34%)
GNOM : 18.44 (-1.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade GNOM with:

Fund Summary

The Global X Genomics and Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.

See More

Top 10 Holdings

Name % Holdings
ULTRAGENYX PHARM 6.11%
SAREPTA THERAPEUTICS INC 6.00%
QIAGEN N.V. 6.00%
ALNYLAM PHARMACE 5.98%
Vertex Pharmaceuticals Inc 5.62%
BIOMARIN PHARMAC 5.44%
PTC THERAPEUTICS INC 4.63%
NATERA INC 4.60%
AGILENT TECHNOLOGIES INC 4.19%
ILLUMINA INC 3.90%

See More

Key Turning Points

2nd Resistance Point 19.28
1st Resistance Point 19.03
Last Price 18.44
1st Support Level 18.47
2nd Support Level 18.17

See More

52-Week High 18.97
Last Price 18.44
Fibonacci 61.8% 15.61
Fibonacci 50% 14.57
Fibonacci 38.2% 13.53
52-Week Low 10.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar